Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Docosahexaenoic Acids | 28 | 2024 | 907 | 4.600 |
Why?
|
Inflammation Mediators | 15 | 2024 | 1886 | 2.010 |
Why?
|
Wound Healing | 8 | 2021 | 2805 | 1.440 |
Why?
|
Inflammation | 28 | 2024 | 10774 | 1.160 |
Why?
|
Macrophages | 24 | 2024 | 5767 | 1.120 |
Why?
|
Atherosclerosis | 11 | 2024 | 3407 | 1.080 |
Why?
|
Peritonitis | 8 | 2019 | 368 | 1.070 |
Why?
|
Lipid Metabolism | 11 | 2024 | 1902 | 1.050 |
Why?
|
Adipose Tissue, Brown | 3 | 2024 | 764 | 0.850 |
Why?
|
Acetanilides | 1 | 2024 | 169 | 0.840 |
Why?
|
Receptors, Formyl Peptide | 4 | 2020 | 146 | 0.830 |
Why?
|
Ischemia | 3 | 2020 | 1884 | 0.750 |
Why?
|
Receptors, Lipoxin | 2 | 2020 | 83 | 0.720 |
Why?
|
Cold Temperature | 1 | 2024 | 785 | 0.710 |
Why?
|
Aldehydes | 4 | 2009 | 170 | 0.700 |
Why?
|
Plaque, Atherosclerotic | 6 | 2021 | 1532 | 0.690 |
Why?
|
Arachidonic Acid | 4 | 2021 | 427 | 0.660 |
Why?
|
Anti-Inflammatory Agents | 7 | 2020 | 1809 | 0.650 |
Why?
|
Wound Infection | 1 | 2021 | 246 | 0.620 |
Why?
|
Fatty Acids, Omega-3 | 5 | 2019 | 1390 | 0.620 |
Why?
|
Phagocytosis | 9 | 2024 | 1528 | 0.610 |
Why?
|
Cyclooxygenase 2 | 4 | 2021 | 597 | 0.610 |
Why?
|
Skin | 3 | 2021 | 4484 | 0.580 |
Why?
|
Eicosapentaenoic Acid | 5 | 2019 | 561 | 0.580 |
Why?
|
Macrophages, Peritoneal | 3 | 2017 | 238 | 0.560 |
Why?
|
Thiazoles | 1 | 2024 | 1517 | 0.550 |
Why?
|
Receptors, CCR7 | 1 | 2016 | 107 | 0.520 |
Why?
|
Regeneration | 3 | 2019 | 1512 | 0.480 |
Why?
|
Cardiovascular Diseases | 6 | 2023 | 15502 | 0.470 |
Why?
|
Activating Transcription Factor 3 | 1 | 2015 | 59 | 0.470 |
Why?
|
Dinoprostone | 3 | 2023 | 597 | 0.460 |
Why?
|
Fatty Acids, Unsaturated | 2 | 2016 | 540 | 0.460 |
Why?
|
Hindlimb | 1 | 2016 | 513 | 0.460 |
Why?
|
Animals | 57 | 2024 | 168475 | 0.450 |
Why?
|
Zymosan | 4 | 2024 | 134 | 0.450 |
Why?
|
Gene Expression Regulation, Enzymologic | 3 | 2015 | 1171 | 0.440 |
Why?
|
Mice | 38 | 2024 | 81539 | 0.440 |
Why?
|
Phospholipids | 4 | 2021 | 786 | 0.440 |
Why?
|
Obesity | 10 | 2022 | 12947 | 0.440 |
Why?
|
Aldehyde Reductase | 3 | 2009 | 71 | 0.430 |
Why?
|
Adipose Tissue | 3 | 2016 | 3313 | 0.430 |
Why?
|
Receptors, Leukotriene B4 | 2 | 2024 | 92 | 0.430 |
Why?
|
Fatty Acids | 3 | 2021 | 1808 | 0.430 |
Why?
|
Prostaglandin D2 | 1 | 2013 | 108 | 0.430 |
Why?
|
Neovascularization, Physiologic | 1 | 2020 | 1349 | 0.420 |
Why?
|
Peripheral Arterial Disease | 4 | 2019 | 1273 | 0.410 |
Why?
|
Insulin Resistance | 4 | 2022 | 3964 | 0.370 |
Why?
|
Ulcer | 1 | 2012 | 204 | 0.360 |
Why?
|
Mice, Inbred C57BL | 19 | 2024 | 22174 | 0.340 |
Why?
|
Neutrophils | 6 | 2023 | 3767 | 0.340 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2019 | 12149 | 0.340 |
Why?
|
Mice, Knockout | 14 | 2024 | 14417 | 0.330 |
Why?
|
Arachidonate 12-Lipoxygenase | 2 | 2019 | 82 | 0.320 |
Why?
|
Metabolome | 1 | 2014 | 989 | 0.290 |
Why?
|
Glutathione | 2 | 2009 | 583 | 0.280 |
Why?
|
Lipids | 4 | 2022 | 3341 | 0.280 |
Why?
|
Metabolic Diseases | 1 | 2013 | 683 | 0.280 |
Why?
|
Keratinocytes | 3 | 2021 | 791 | 0.270 |
Why?
|
Dietary Fats | 3 | 2022 | 1995 | 0.260 |
Why?
|
Thrombosis | 2 | 2017 | 2942 | 0.250 |
Why?
|
Cholesterol | 1 | 2014 | 2905 | 0.250 |
Why?
|
Hydroxyeicosatetraenoic Acids | 2 | 2024 | 224 | 0.250 |
Why?
|
Macrophage Activation | 3 | 2020 | 553 | 0.250 |
Why?
|
Immunity, Innate | 2 | 2016 | 3066 | 0.250 |
Why?
|
Wounds and Injuries | 1 | 2018 | 2492 | 0.250 |
Why?
|
Receptors, G-Protein-Coupled | 5 | 2024 | 1252 | 0.240 |
Why?
|
Early Growth Response Protein 2 | 1 | 2024 | 25 | 0.240 |
Why?
|
Adrenergic beta-3 Receptor Agonists | 1 | 2024 | 14 | 0.240 |
Why?
|
Lymph Nodes | 1 | 2016 | 3465 | 0.240 |
Why?
|
Arginase | 1 | 2024 | 80 | 0.220 |
Why?
|
Aspirin | 4 | 2016 | 3133 | 0.220 |
Why?
|
Mice, Obese | 2 | 2016 | 420 | 0.220 |
Why?
|
Lipoxins | 3 | 2011 | 419 | 0.220 |
Why?
|
Cell Movement | 5 | 2021 | 5205 | 0.220 |
Why?
|
Aspergillus fumigatus | 1 | 2024 | 157 | 0.210 |
Why?
|
Leukocytes | 2 | 2017 | 2026 | 0.210 |
Why?
|
PPAR gamma | 3 | 2016 | 484 | 0.210 |
Why?
|
Isoenzymes | 1 | 2007 | 1687 | 0.210 |
Why?
|
Thermogenesis | 2 | 2024 | 475 | 0.200 |
Why?
|
Muscle, Skeletal | 4 | 2020 | 4948 | 0.200 |
Why?
|
Macrophages, Alveolar | 1 | 2024 | 412 | 0.200 |
Why?
|
Coenzyme A Ligases | 1 | 2021 | 45 | 0.200 |
Why?
|
Metabolomics | 1 | 2011 | 1659 | 0.190 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2023 | 241 | 0.190 |
Why?
|
Receptor Protein-Tyrosine Kinases | 3 | 2019 | 1626 | 0.180 |
Why?
|
Aorta | 2 | 2020 | 2041 | 0.180 |
Why?
|
Arachidonate 5-Lipoxygenase | 3 | 2017 | 128 | 0.180 |
Why?
|
Cells, Cultured | 8 | 2021 | 18966 | 0.180 |
Why?
|
Cold-Shock Response | 1 | 2019 | 16 | 0.170 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 2273 | 0.160 |
Why?
|
Humans | 40 | 2024 | 761596 | 0.150 |
Why?
|
Oxidative Stress | 1 | 2009 | 3113 | 0.150 |
Why?
|
Disease Models, Animal | 9 | 2020 | 18255 | 0.150 |
Why?
|
Acyltransferases | 1 | 2019 | 305 | 0.150 |
Why?
|
Neointima | 1 | 2018 | 133 | 0.150 |
Why?
|
Carotid Artery, Common | 1 | 2018 | 175 | 0.150 |
Why?
|
Myocytes, Smooth Muscle | 3 | 2017 | 699 | 0.140 |
Why?
|
Fatty Acid Desaturases | 1 | 2017 | 100 | 0.140 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2012 | 3415 | 0.140 |
Why?
|
Fatty Liver | 1 | 2023 | 790 | 0.140 |
Why?
|
Gene Knockout Techniques | 1 | 2020 | 802 | 0.140 |
Why?
|
Jugular Veins | 1 | 2018 | 210 | 0.140 |
Why?
|
Growth Differentiation Factor 3 | 1 | 2016 | 11 | 0.140 |
Why?
|
Interleukin-4 | 1 | 2021 | 1149 | 0.140 |
Why?
|
Molecular Structure | 3 | 2017 | 1880 | 0.140 |
Why?
|
Prostaglandins | 2 | 2021 | 398 | 0.130 |
Why?
|
Male | 29 | 2024 | 360846 | 0.130 |
Why?
|
Mice, Inbred Strains | 2 | 2009 | 1762 | 0.130 |
Why?
|
Drug Implants | 1 | 2016 | 230 | 0.130 |
Why?
|
Lipogenesis | 1 | 2017 | 214 | 0.130 |
Why?
|
Energy Metabolism | 2 | 2019 | 2882 | 0.130 |
Why?
|
Mice, 129 Strain | 1 | 2016 | 371 | 0.130 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 3246 | 0.130 |
Why?
|
Sepsis | 1 | 2009 | 2585 | 0.130 |
Why?
|
Myoblasts | 1 | 2016 | 231 | 0.130 |
Why?
|
Rats, Sprague-Dawley | 2 | 2024 | 8181 | 0.120 |
Why?
|
Monocytes | 3 | 2014 | 2570 | 0.120 |
Why?
|
Graft Occlusion, Vascular | 1 | 2018 | 537 | 0.120 |
Why?
|
Membranes, Artificial | 1 | 2016 | 366 | 0.120 |
Why?
|
Mechanical Phenomena | 1 | 2015 | 141 | 0.120 |
Why?
|
Absorbable Implants | 1 | 2016 | 338 | 0.110 |
Why?
|
Proto-Oncogene Proteins | 2 | 2017 | 4514 | 0.110 |
Why?
|
Radiation Injuries | 1 | 2021 | 1189 | 0.110 |
Why?
|
Bed Rest | 1 | 2014 | 83 | 0.110 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2014 | 174 | 0.110 |
Why?
|
Receptors, Prostaglandin | 1 | 2013 | 53 | 0.110 |
Why?
|
Receptors, Prostaglandin E, EP2 Subtype | 1 | 2013 | 48 | 0.110 |
Why?
|
Xanthones | 1 | 2013 | 23 | 0.110 |
Why?
|
Leukotriene B4 | 1 | 2014 | 280 | 0.110 |
Why?
|
Platelet Activation | 1 | 2017 | 645 | 0.110 |
Why?
|
Bone Marrow | 1 | 2023 | 2911 | 0.110 |
Why?
|
Mice, Transgenic | 5 | 2021 | 9542 | 0.110 |
Why?
|
Hypothermia | 1 | 2014 | 188 | 0.100 |
Why?
|
Palmitic Acid | 1 | 2013 | 149 | 0.100 |
Why?
|
Acute Lung Injury | 1 | 2016 | 367 | 0.100 |
Why?
|
Abdominal Fat | 1 | 2014 | 221 | 0.100 |
Why?
|
Necrosis | 3 | 2024 | 1611 | 0.100 |
Why?
|
Acute Disease | 2 | 2015 | 7237 | 0.100 |
Why?
|
Immunoblotting | 2 | 2014 | 1646 | 0.100 |
Why?
|
Fish Oils | 1 | 2015 | 483 | 0.100 |
Why?
|
Aortic Diseases | 1 | 2017 | 735 | 0.100 |
Why?
|
Receptors, LDL | 3 | 2020 | 488 | 0.090 |
Why?
|
Fossils | 1 | 2011 | 75 | 0.090 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2013 | 321 | 0.090 |
Why?
|
Adaptive Immunity | 1 | 2016 | 726 | 0.090 |
Why?
|
Endothelial Cells | 2 | 2017 | 3549 | 0.090 |
Why?
|
Leukotrienes | 1 | 2012 | 231 | 0.090 |
Why?
|
Female | 19 | 2024 | 392705 | 0.090 |
Why?
|
Carrageenan | 2 | 2023 | 71 | 0.090 |
Why?
|
Apoptosis | 4 | 2021 | 9490 | 0.090 |
Why?
|
Carotid Artery Diseases | 1 | 2017 | 877 | 0.090 |
Why?
|
Eicosanoids | 1 | 2012 | 282 | 0.090 |
Why?
|
Dyslipidemias | 1 | 2017 | 868 | 0.090 |
Why?
|
Cardiovascular Agents | 1 | 2016 | 840 | 0.090 |
Why?
|
Blood Platelets | 1 | 2020 | 2479 | 0.090 |
Why?
|
Peritoneal Cavity | 1 | 2009 | 135 | 0.080 |
Why?
|
Immunomodulation | 1 | 2013 | 549 | 0.080 |
Why?
|
Autacoids | 1 | 2008 | 17 | 0.080 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2012 | 705 | 0.080 |
Why?
|
Lipoxygenase | 1 | 2008 | 72 | 0.080 |
Why?
|
Interleukin-10 | 1 | 2014 | 1175 | 0.080 |
Why?
|
Hematopoietic Stem Cells | 1 | 2021 | 3397 | 0.080 |
Why?
|
Receptors, Fc | 1 | 2012 | 535 | 0.080 |
Why?
|
Chemokine CCL2 | 1 | 2011 | 605 | 0.080 |
Why?
|
Muscle, Smooth, Vascular | 2 | 2016 | 1492 | 0.080 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2018 | 1428 | 0.080 |
Why?
|
Temporomandibular Joint Disorders | 1 | 2011 | 222 | 0.070 |
Why?
|
Swine | 1 | 2018 | 5915 | 0.070 |
Why?
|
Glucose Tolerance Test | 1 | 2011 | 1178 | 0.070 |
Why?
|
Stereoisomerism | 1 | 2008 | 614 | 0.070 |
Why?
|
Immunity, Cellular | 1 | 2013 | 1560 | 0.070 |
Why?
|
Immunity | 1 | 2013 | 996 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 4576 | 0.070 |
Why?
|
Oxidation-Reduction | 3 | 2009 | 2231 | 0.070 |
Why?
|
Body Composition | 1 | 2016 | 2426 | 0.070 |
Why?
|
Dietary Supplements | 2 | 2019 | 3415 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2021 | 10766 | 0.070 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2020 | 3080 | 0.070 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7593 | 0.070 |
Why?
|
Phosphorylation | 3 | 2014 | 8321 | 0.070 |
Why?
|
Autophagy | 1 | 2014 | 1327 | 0.070 |
Why?
|
Oligonucleotides, Antisense | 2 | 2020 | 461 | 0.070 |
Why?
|
Homeostasis | 2 | 2022 | 3323 | 0.060 |
Why?
|
Adipocytes | 1 | 2012 | 1194 | 0.060 |
Why?
|
Adiponectin | 1 | 2011 | 1113 | 0.060 |
Why?
|
Dendritic Cells | 1 | 2016 | 2747 | 0.060 |
Why?
|
Peptides | 1 | 2017 | 4358 | 0.060 |
Why?
|
Aging | 2 | 2023 | 8710 | 0.060 |
Why?
|
Adiposity | 1 | 2014 | 1879 | 0.060 |
Why?
|
Mass Spectrometry | 1 | 2011 | 2192 | 0.060 |
Why?
|
Apolipoproteins E | 1 | 2009 | 1443 | 0.060 |
Why?
|
Cytokines | 3 | 2017 | 7396 | 0.060 |
Why?
|
Gene Deletion | 1 | 2011 | 2665 | 0.060 |
Why?
|
Substrate Specificity | 1 | 2007 | 1791 | 0.050 |
Why?
|
Blotting, Western | 3 | 2016 | 5035 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2016 | 4758 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2019 | 7859 | 0.050 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2016 | 4580 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2011 | 2457 | 0.050 |
Why?
|
Radiation | 1 | 2021 | 49 | 0.050 |
Why?
|
Leukocytes, Mononuclear | 1 | 2008 | 1844 | 0.050 |
Why?
|
Phenotype | 3 | 2020 | 16592 | 0.050 |
Why?
|
Caspase 3 | 1 | 2024 | 731 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2014 | 4431 | 0.050 |
Why?
|
Reactive Oxygen Species | 1 | 2009 | 2139 | 0.050 |
Why?
|
Hypertrophy | 2 | 2014 | 561 | 0.050 |
Why?
|
Signal Transduction | 3 | 2020 | 23447 | 0.050 |
Why?
|
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2021 | 65 | 0.050 |
Why?
|
Middle Aged | 6 | 2024 | 220921 | 0.050 |
Why?
|
Calcium | 1 | 2014 | 5722 | 0.050 |
Why?
|
Reperfusion Injury | 2 | 2019 | 1023 | 0.050 |
Why?
|
Interleukin-6 | 1 | 2011 | 3208 | 0.050 |
Why?
|
Genes, p16 | 1 | 2021 | 160 | 0.050 |
Why?
|
Rabbits | 2 | 2018 | 4772 | 0.050 |
Why?
|
Vascular System Injuries | 1 | 2024 | 246 | 0.050 |
Why?
|
Protein Kinases | 2 | 2021 | 1608 | 0.050 |
Why?
|
Nitric Oxide | 1 | 2009 | 2136 | 0.040 |
Why?
|
Antibodies | 2 | 2020 | 2418 | 0.040 |
Why?
|
Liver | 2 | 2017 | 7528 | 0.040 |
Why?
|
Neuropilin-1 | 1 | 2020 | 90 | 0.040 |
Why?
|
Acylation | 1 | 2019 | 96 | 0.040 |
Why?
|
Apolipoprotein B-100 | 1 | 2020 | 157 | 0.040 |
Why?
|
Culture Media, Conditioned | 1 | 2020 | 522 | 0.040 |
Why?
|
Nanoparticles | 1 | 2011 | 1958 | 0.040 |
Why?
|
Administration, Oral | 2 | 2019 | 4021 | 0.040 |
Why?
|
Young Adult | 2 | 2024 | 59260 | 0.040 |
Why?
|
Rats | 3 | 2024 | 23741 | 0.040 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2020 | 306 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2021 | 496 | 0.040 |
Why?
|
Epigenomics | 1 | 2024 | 943 | 0.040 |
Why?
|
Poloxamer | 1 | 2018 | 56 | 0.040 |
Why?
|
Adipocytes, Brown | 1 | 2019 | 150 | 0.040 |
Why?
|
MicroRNAs | 1 | 2014 | 3816 | 0.040 |
Why?
|
Hypoglycemic Agents | 1 | 2011 | 3085 | 0.040 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2021 | 598 | 0.040 |
Why?
|
Escherichia coli | 1 | 2009 | 4217 | 0.040 |
Why?
|
Gels | 1 | 2018 | 420 | 0.040 |
Why?
|
Blood Glucose | 1 | 2011 | 6391 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2013 | 10212 | 0.030 |
Why?
|
Insulin | 1 | 2011 | 6597 | 0.030 |
Why?
|
Fibrosis | 1 | 2023 | 2049 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2017 | 11461 | 0.030 |
Why?
|
Muscle Stretching Exercises | 1 | 2015 | 37 | 0.030 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2018 | 662 | 0.030 |
Why?
|
San Francisco | 1 | 2015 | 162 | 0.030 |
Why?
|
Cell Line | 2 | 2019 | 15601 | 0.030 |
Why?
|
Collagen | 1 | 2023 | 2638 | 0.030 |
Why?
|
Hyperplasia | 1 | 2018 | 1152 | 0.030 |
Why?
|
Polyglycolic Acid | 1 | 2016 | 406 | 0.030 |
Why?
|
Citrate (si)-Synthase | 1 | 2014 | 48 | 0.030 |
Why?
|
Placebos | 1 | 2019 | 1667 | 0.030 |
Why?
|
Molecular Sequence Data | 1 | 2007 | 17635 | 0.030 |
Why?
|
Electron Transport Complex IV | 1 | 2014 | 190 | 0.030 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2016 | 855 | 0.030 |
Why?
|
Drug Carriers | 1 | 2018 | 706 | 0.030 |
Why?
|
Brachial Artery | 1 | 2015 | 366 | 0.030 |
Why?
|
Connective Tissue | 1 | 2015 | 419 | 0.030 |
Why?
|
Cohort Studies | 1 | 2016 | 41495 | 0.030 |
Why?
|
Citric Acid Cycle | 1 | 2014 | 231 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2019 | 12341 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1935 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2023 | 2451 | 0.030 |
Why?
|
Cell Size | 1 | 2014 | 624 | 0.030 |
Why?
|
Lung Injury | 1 | 2016 | 422 | 0.020 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2014 | 687 | 0.020 |
Why?
|
Protein Transport | 1 | 2017 | 1967 | 0.020 |
Why?
|
Vasodilation | 1 | 2015 | 962 | 0.020 |
Why?
|
PPAR alpha | 1 | 2012 | 175 | 0.020 |
Why?
|
Lactic Acid | 1 | 2016 | 1139 | 0.020 |
Why?
|
Toll-Like Receptors | 1 | 2014 | 589 | 0.020 |
Why?
|
Cell Separation | 1 | 2016 | 1720 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2024 | 3801 | 0.020 |
Why?
|
Serine | 1 | 2014 | 831 | 0.020 |
Why?
|
Exercise Tolerance | 1 | 2015 | 836 | 0.020 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2010 | 178 | 0.020 |
Why?
|
Molecular Mimicry | 1 | 2011 | 213 | 0.020 |
Why?
|
Cytoplasm | 1 | 2014 | 1510 | 0.020 |
Why?
|
Imidazolidines | 1 | 2009 | 38 | 0.020 |
Why?
|
Adult | 1 | 2024 | 221210 | 0.020 |
Why?
|
Temporomandibular Joint | 1 | 2011 | 201 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2017 | 11904 | 0.020 |
Why?
|
Naphthalenes | 1 | 2009 | 198 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2014 | 1971 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2016 | 3779 | 0.020 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2010 | 618 | 0.020 |
Why?
|
Microspheres | 1 | 2011 | 784 | 0.020 |
Why?
|
Triglycerides | 1 | 2015 | 2461 | 0.020 |
Why?
|
Glucose | 1 | 2019 | 4347 | 0.020 |
Why?
|
Saphenous Vein | 1 | 2010 | 516 | 0.020 |
Why?
|
Chemotaxis | 1 | 2010 | 598 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2010 | 1704 | 0.020 |
Why?
|
Receptors, Chemokine | 1 | 2010 | 652 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2011 | 983 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2016 | 6214 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3639 | 0.020 |
Why?
|
Amino Acids | 1 | 2012 | 1718 | 0.020 |
Why?
|
Gene Expression | 1 | 2019 | 7581 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2014 | 2910 | 0.020 |
Why?
|
Time Factors | 2 | 2018 | 39969 | 0.020 |
Why?
|
Phospholipid Ethers | 1 | 2004 | 9 | 0.020 |
Why?
|
Aged | 4 | 2023 | 169310 | 0.020 |
Why?
|
Phosphatidic Acids | 1 | 2004 | 49 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2011 | 1188 | 0.010 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2014 | 1899 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2872 | 0.010 |
Why?
|
Lipid Peroxidation | 1 | 2004 | 271 | 0.010 |
Why?
|
Glycerol | 1 | 2004 | 274 | 0.010 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2009 | 1119 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9420 | 0.010 |
Why?
|
Catalysis | 1 | 2004 | 774 | 0.010 |
Why?
|
COS Cells | 1 | 2004 | 1130 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2018 | 10451 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13510 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11076 | 0.010 |
Why?
|
Models, Chemical | 1 | 2004 | 611 | 0.010 |
Why?
|
Pain | 1 | 2015 | 5073 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 64685 | 0.010 |
Why?
|
Cell Survival | 1 | 2010 | 5791 | 0.010 |
Why?
|
Up-Regulation | 1 | 2009 | 4125 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2010 | 5870 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 2898 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2009 | 3713 | 0.010 |
Why?
|
Blood Pressure | 1 | 2014 | 8481 | 0.010 |
Why?
|
Kinetics | 1 | 2004 | 6374 | 0.010 |
Why?
|
Protein Conformation | 1 | 2004 | 3968 | 0.010 |
Why?
|
Binding Sites | 1 | 2004 | 6056 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2010 | 12794 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2004 | 6534 | 0.010 |
Why?
|
Models, Molecular | 1 | 2004 | 5439 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 58984 | 0.010 |
Why?
|
Oxygen | 1 | 2004 | 4227 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2010 | 22176 | 0.010 |
Why?
|
Protein Binding | 1 | 2004 | 9353 | 0.010 |
Why?
|
Models, Biological | 1 | 2004 | 9469 | 0.000 |
Why?
|
Prospective Studies | 1 | 2010 | 54423 | 0.000 |
Why?
|